Actinic Keratosis Treatment Market Size, Sector / Industry Report & Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Actinic Keratosis Treatment Market


The global Actinic Keratosis Treatment market size is projected to reach US$ 9.17 billion by 2026, from US$ 6.92 billion in 2020, at a CAGR of 4.8% during 2021-2026. Increase in disease prevalence, aided by environmental factors, such as ozone depletion and excessive sun exposure, is one of the key drivers for market growth.

Actinic keratosis is the most prevalent class of precancerous skin lesions. Nearly 50% of all squamous cell carcinoma cases arise from untreated or inappropriately treated actinic keratoses. Preventive strategies for cancer are the major propeller for increased treatment rates of actinic keratosis.

Several awareness campaigns organized by public and private groups are anticipated to catalyze consumer awareness about the disease and its comorbidities. In addition, favorable reimbursement policies to expand the affordability will drive market growth.

The impending launch of pipeline products, combined with the research and development of novel treatments with improved efficacy, convenient dosage, and reduced cost, indicates a promising future for the actinic keratosis treatment market.

Market Segmentation, Outlook & Viewpoint: Global Actinic Keratosis Treatment Market

Therapy Market Segmentation & Outlook (Revenue, USD Million; 2014 - 2026)

  
Topical
  
Surgery
  
Photodynamic Therapy

Drug Class Market Segmentation & Outlook (Revenue, USD Million; 2014 - 2026)

  
Nucleoside Metabolic Inhibitors
  
NSAIDs
  
Immune Response Modifiers
  
Photoenhancers
  
Others

End use Market Segmentation & Outlook (Revenue, USD Million; 2014 - 2026)

  
Hospitals
  
Private Clinics
  
Homecare
  
Others

Key Players, Recent Developments & Regional Insights: Global Actinic Keratosis Treatment Market

Hospitals end use segment led the market, in 2018. The growth is driven by ease of accessibility and availability to patients. The rise in healthcare infrastructure, especially in developing economies, is a key driver.
Homecare is anticipated to demonstrate a rapid growth over the forecast period, supported by high consumer awareness and self-care treatment options. Furthermore, increasing opportunities for caregivers and nurses for home healthcare services are a major propeller for actinic keratosis treatment market growth.

Drug Class Insights

Nucleoside metabolic inhibitors held the largest market share in 2018, and is anticipated to continue through the forecast period. The market growth is driven by steady sales of Carac, Efudex, Fluoroplex, and Tolak. However, generic penetration is likely to have a negative impact on the market.

Photoenhancers are projected to witness a healthy growth over the next few years by virtue of strong commercial opportunities and relatively low competitive rivalry. NSAIDs and immune response modifiers are forecasted to maintain their market shares in the foreseeable future.

Regional Insights

North America led the market in 2018, by contributing nearly 35.0% to the overall revenue share, driven by an increasing disease prevalence and proactive government initiatives. Local presence of key manufacturers as well as regulatory entities is anticipated to foster market growth in the near future.

Asia Pacific is estimated to expand at a lucrative CAGR over the forecast period. The high prevalence of the disease in southern areas, such as Australia and New Zealand, is the major regional growth driver. In addition, increasing disposable income and rise in consumer awareness contribute significantly to the rapid regional growth.
Actinic Keratosis Treatment Market Share Insights

Some key players in the market include Bausch Health Companies Inc.; LEO Pharma A/S; Almirall, S.A.; Biofrontera, Inc.; Nestle S.A.; Sun Pharmaceutical Industries Ltd.; Novartis International AG; 3M Pharmaceuticals Inc.; Hill Dermaceuticals, Inc.; and Mylan N.V.

Innovative research and development, such as photodynamic therapy, plays a key role in entrance of new players in this market. In addition, key players are adopting various strategies such as mergers and acquisitions, new product developments, and promoting awareness initiatives to maintain their market share.

Key Insights Covered: Global Actinic Keratosis Treatment Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Actinic Keratosis Treatment industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Actinic Keratosis Treatment industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Actinic Keratosis Treatment industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Actinic Keratosis Treatment industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Actinic Keratosis Treatment industry.

Research Methodology: Global Actinic Keratosis Treatment Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other